| Primary |
| Hypertension |
51.4% |
| Product Used For Unknown Indication |
22.0% |
| Essential Hypertension |
5.8% |
| Drug Use For Unknown Indication |
2.9% |
| Diabetes Mellitus |
1.6% |
| Hypertension Arterial |
1.6% |
| Arthralgia |
1.3% |
| Dyslipidaemia |
1.3% |
| Gestational Hypertension |
1.3% |
| Ischaemic Stroke |
1.3% |
| Hyperlipidaemia |
1.1% |
| Pain |
1.1% |
| Prophylaxis |
1.1% |
| Pyrexia |
1.1% |
| Back Pain |
0.9% |
| Blood Pressure |
0.9% |
| Hyperuricaemia |
0.9% |
| Pain In Extremity |
0.9% |
| Asthma |
0.7% |
| Atrial Fibrillation |
0.7% |
|
| Renal Failure Acute |
10.4% |
| Vomiting |
9.4% |
| Thrombocytopenia |
8.3% |
| Weight Decreased |
8.3% |
| Hepatic Function Abnormal |
6.3% |
| Hypotension |
6.3% |
| Renal Failure |
5.2% |
| Loss Of Consciousness |
4.2% |
| Renal Disorder |
4.2% |
| Renal Impairment |
4.2% |
| Shock |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Cerebral Infarction |
3.1% |
| Death |
3.1% |
| Hepatitis Acute |
3.1% |
| Hyperkalaemia |
3.1% |
| Hyponatraemia |
3.1% |
| Interstitial Lung Disease |
3.1% |
| Malaise |
3.1% |
| Nausea |
3.1% |
|
| Secondary |
| Hypertension |
45.6% |
| Drug Use For Unknown Indication |
12.5% |
| Product Used For Unknown Indication |
7.4% |
| Essential Hypertension |
3.5% |
| Diabetes Mellitus |
3.4% |
| Hyperlipidaemia |
3.0% |
| Dyslipidaemia |
2.9% |
| Self Mutilation |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Insomnia |
2.1% |
| Hyperuricaemia |
2.0% |
| Interstitial Lung Disease |
1.9% |
| Gastric Ulcer |
1.7% |
| Rheumatoid Arthritis |
1.5% |
| Sedation |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Atrial Fibrillation |
1.1% |
| Pain |
1.1% |
| Cerebrovascular Accident |
1.0% |
| Constipation |
1.0% |
|
| Death |
14.9% |
| Renal Impairment |
8.5% |
| Renal Failure Acute |
8.0% |
| Hepatic Function Abnormal |
7.5% |
| Rhabdomyolysis |
6.0% |
| Toxic Epidermal Necrolysis |
6.0% |
| White Blood Cell Count Increased |
6.0% |
| Hyperkalaemia |
5.0% |
| Vomiting |
5.0% |
| Syncope |
4.5% |
| Interstitial Lung Disease |
3.5% |
| Platelet Count Decreased |
3.5% |
| Prostate Cancer |
3.5% |
| Malaise |
3.0% |
| Thrombocytopenia |
3.0% |
| Lactic Acidosis |
2.5% |
| Leukocytoclastic Vasculitis |
2.5% |
| Liver Disorder |
2.5% |
| Loss Of Consciousness |
2.5% |
| Renal Failure |
2.5% |
|
| Concomitant |
| Hypertension |
31.5% |
| Product Used For Unknown Indication |
8.1% |
| Drug Use For Unknown Indication |
7.9% |
| Rheumatoid Arthritis |
7.5% |
| Prophylaxis |
6.8% |
| Chronic Hepatitis C |
5.4% |
| Diabetes Mellitus |
4.7% |
| Type 2 Diabetes Mellitus |
3.1% |
| Insomnia |
3.0% |
| Constipation |
3.0% |
| Hepatitis C |
2.4% |
| Hyperlipidaemia |
2.3% |
| Gastritis |
2.2% |
| Psoriasis |
2.2% |
| Angina Pectoris |
2.0% |
| Atrial Fibrillation |
2.0% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Osteoporosis |
1.6% |
| Gastric Ulcer |
1.3% |
| Hyperuricaemia |
1.3% |
|
| Renal Impairment |
10.6% |
| Vomiting |
10.6% |
| White Blood Cell Count Decreased |
9.2% |
| Rash |
7.0% |
| Interstitial Lung Disease |
6.0% |
| Pyrexia |
5.3% |
| Rhabdomyolysis |
5.3% |
| Renal Failure Acute |
4.9% |
| Renal Disorder |
4.8% |
| Hepatic Function Abnormal |
4.4% |
| White Blood Cell Count Increased |
3.8% |
| Hypertension |
3.5% |
| Hypoglycaemia |
3.5% |
| Stomatitis |
3.5% |
| Death |
3.1% |
| Pneumonia |
3.1% |
| Malaise |
2.9% |
| Thrombocytopenia |
2.9% |
| Loss Of Consciousness |
2.7% |
| Urinary Tract Infection |
2.7% |
|
| Interacting |
| Hypertension |
40.0% |
| Pain |
20.0% |
| Diabetes Mellitus |
8.6% |
| Alcoholism |
5.7% |
| Insomnia |
5.7% |
| Renal Cancer |
5.7% |
| Sedative Therapy |
5.7% |
| Diarrhoea |
2.9% |
| Product Used For Unknown Indication |
2.9% |
| Tendonitis |
2.9% |
|
| Renal Failure Acute |
33.3% |
| Renal Failure |
22.2% |
| Drug Interaction |
11.1% |
| Hyponatraemia |
11.1% |
| Medication Error |
11.1% |
| Vomiting |
11.1% |
|
